Aranesp news from FierceHealthcare
NewsFDA demands new labels for Amgen anemia drugs
The FDA has demanded that drugmaker Amgen change the labels for its top-selling anemia drugs in a way which could further limit their use in treating cancer patients. In making the order, the FDA Read more...
|
